The pharmaceutical landscape for diabetes is evolving, and GLP-1 patches represent a exciting advance. Unlike shots, this approach offers a less invasive way to administer GLP-1 therapies. These patches steadily release the treatment through the epidermis offering a even level of the beneficial a